Detalles de la búsqueda
1.
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.
Int J Clin Oncol
; 28(5): 654-663, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856908
2.
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.
Br J Cancer
; 117(10): 1450-1458, 2017 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28972961
3.
Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.
Cancer Sci
; 104(7): 896-903, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23578175
4.
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing.
Biomed Rep
; 11(4): 171-180, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31565223
5.
Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment.
Genome Biol
; 16: 66, 2015 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887790
6.
Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts.
PLoS One
; 8(9): e73484, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24069199
Resultados
1 -
6
de 6
1
Próxima >
>>